Thursday, October 31, 2019 10:38:13 AM
decision PR to continue or stop for efficacy by next
Monday or Tuesday, to continue, 20% down side risk? To
stop for efficay, $12 to $15 price target, IMO. Now
I understand why CLSN chooses HR as target, not P value
the normal trial value designed for interim efficacy,
for best chance to stop for efficacy if OPTIMA is to
repeat the subgroup OS KM curves, IMO. I am betting
stop for efficacy next week, good luck!
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM